Made-to-order human kidneys one step closer

Image
Press Trust of India Tokyo
Last Updated : Feb 06 2019 | 4:05 PM IST

Researchers say they have successfully grown functional kidneys inside rats using just a few donor stem cells, an advance with significant implications for human organ transplantation.

For patients with end-stage renal disease, a kidney transplant is the only hope for regaining quality of life, according to the study published in the journal Nature Communications.

Yet many of these patients will never undergo transplant surgery due to a chronic shortage of donor kidneys, said researchers from the National Institute for Physiological Sciences in Japan.

With 95,000 patients on the waiting list for a donor kidney in the US alone, demand far outstrips supply, they said.

However, researchers have been working on ways to grow healthy organs outside the human body.

One such method, called blastocyst complementation, has already produced promising results.

Researchers take blastocysts, the clusters of cells formed several days after egg fertilisation, from mutant animals missing specific organs and inject them with stem cells from a normal donor, not necessarily of the same species.

The stem cells then differentiate to form the entire missing organ in the resulting animal.

The new organ retains the characteristics of the original stem cell donor, and can thus potentially be used in transplantation therapy.

"We previously used blastocyst complementation to generate rat pancreas in a pancreatic mutant mice," said Teppei Goto, the lead author of the study.

"We therefore decided to investigate whether the method could be used to generate functional kidneys, which would have much greater application in regenerative medicine owing to the high donor demand," Goto said.

Initial attempts by the researchers to grow rat kidneys in mice proved unsuccessful, as rat stem cells did not readily differentiate into the two main types of cells needed for kidney formation.

However, when the reverse scenario was attempted, mouse stem cells efficiently differentiated inside rat blastocysts, forming the basic structures of a kidney.

After being implanted into pseudo-pregnant rats, the complemented blastocysts matured into normal fetuses, researchers said.

More than two thirds of the resulting rat neonates contained a pair of kidneys derived from the mouse stem cells.

Further screening showed that all of the kidneys were structurally intact, and at least half could potentially produce urine.

"Our findings confirm that interspecific blastocyst complementation is a viable method for kidney generation," said study corresponding author Masumi Hirabayashi.

"In the future, this approach could be used to generate human stem cell-derived organs in livestock, potentially extending the lifespan and improving the quality of life of millions of people worldwide," said Hirabayashi.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 06 2019 | 4:05 PM IST

Next Story